{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:55:00Z","timestamp":1770411300698,"version":"3.49.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,20]]},"DOI":"10.1097\/qad.0b013e328342ff11","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T05:57:43Z","timestamp":1295503063000},"page":"419-428","source":"Crossref","is-referenced-by-count":24,"title":["Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes"],"prefix":"10.1097","volume":"25","author":[{"given":"Henri G","family":"Franquelim","sequence":"first","affiliation":[]},{"given":"Salvatore","family":"Chiantia","sequence":"additional","affiliation":[]},{"given":"Ana Salom\u00e9","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Nuno C","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Petra","family":"Schwille","sequence":"additional","affiliation":[]},{"given":"Miguel ARB","family":"Castanho","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","article-title":"HIV entry and its inhibition","volume":"93","author":"Chan","year":"1998","journal-title":"Cell"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2174\/1381612043384448","article-title":"HIV-1 gp41 as a target for viral entry inhibition","volume":"10","author":"Root","year":"2004","journal-title":"Curr Pharm Des"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003495-200565070-00001","article-title":"The appealing story of HIV entry inhibitors: from discovery of biological mechanisms to drug development","volume":"65","author":"Castagna","year":"2005","journal-title":"Drugs"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/MMBR.00020-07","article-title":"The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design","volume":"72","author":"Montero","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.02588-06","article-title":"An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10","volume":"81","author":"Nelson","year":"2007","journal-title":"J Virol"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1128\/JVI.67.11.6642-6647.1993","article-title":"A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1","volume":"67","author":"Muster","year":"1993","journal-title":"J Virol"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"Zwick","year":"2001","journal-title":"J Virol"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1089\/088922200750054756","article-title":"Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1","volume":"16","author":"Bures","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/JVI.79.2.1154-1163.2005","article-title":"Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein","volume":"79","author":"Gao","year":"2005","journal-title":"J Virol"},{"key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature04817","article-title":"Distribution and three-dimensional structure of AIDS virus envelope spikes","volume":"441","author":"Zhu","year":"2006","journal-title":"Nature"},{"key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"20234","DOI":"10.1073\/pnas.0908713106","article-title":"Role of HIV membrane in neutralization by two broadly neutralizing antibodies","volume":"106","author":"Alam","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(00)01785-3","article-title":"The pretransmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence","volume":"477","author":"Suarez","year":"2000","journal-title":"FEBS Lett"},{"key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.bbamem.2007.12.018","article-title":"Interfacial pretransmembrane domains in viral proteins promoting membrane fusion and fission","volume":"1778","author":"Lorizate","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.immuni.2007.11.018","article-title":"HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane","volume":"28","author":"Sun","year":"2008","journal-title":"Immunity"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1111\/j.1742-4658.2007.06029.x","article-title":"The influence of cholesterol on the interaction of HIV gp41 membrane proximal region-derived peptides with lipid bilayers","volume":"274","author":"Veiga","year":"2007","journal-title":"FEBS J"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"21776","DOI":"10.1074\/jbc.M202255200","article-title":"Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring","volume":"277","author":"Saez-Cirion","year":"2002","journal-title":"J Biol Chem"},{"key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1128\/JVI.69.11.6609-6617.1995","article-title":"Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG","volume":"69","author":"Trkola","year":"1995","journal-title":"J Virol"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/08892220152741450","article-title":"A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1","volume":"17","author":"Stiegler","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s15010-005-6505-y","article-title":"What's new in HIV\/AIDS? Neutralizing HIV antibodies: do they really protect?","volume":"33","author":"Julg","year":"2005","journal-title":"Infection"},{"key":"R20-3-20210130","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/QAD.0b013e328285da15","article-title":"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data","volume":"21","author":"Vcelar","year":"2007","journal-title":"AIDS"},{"key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1128\/JVI.76.7.3511-3521.2002","article-title":"Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins","volume":"76","author":"Grundner","year":"2002","journal-title":"J Virol"},{"key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1074\/jbc.M411088200","article-title":"Trimeric membrane-anchored gp41 inhibits HIV membrane fusion","volume":"280","author":"Lenz","year":"2005","journal-title":"J Biol Chem"},{"key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1128\/JVI.78.19.10724-10737.2004","article-title":"Structure and mechanistic analysis of the antihuman immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope","volume":"78","author":"Ofek","year":"2004","journal-title":"J Virol"},{"key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2004.12.011","article-title":"Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41","volume":"22","author":"Cardoso","year":"2005","journal-title":"Immunity"},{"key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jmb.2008.09.024","article-title":"Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site","volume":"384","author":"Julien","year":"2008","journal-title":"J Mol Biol"},{"key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2006.02.002","article-title":"The membranes' role in the HIV-1 neutralizing monoclonal antibody 2F5 mode of action needs re-evaluation","volume":"71","author":"Veiga","year":"2006","journal-title":"Antiviral Res"},{"key":"R27-3-20210130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/cbic.200800609","article-title":"Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems","volume":"10","author":"Veiga","year":"2009","journal-title":"Chembiochem"},{"key":"R28-3-20210130","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/science.1111781","article-title":"Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies","volume":"308","author":"Haynes","year":"2005","journal-title":"Science"},{"key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.febslet.2006.03.067","article-title":"Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing antigp41 2F5 antibody","volume":"580","author":"Sanchez-Martinez","year":"2006","journal-title":"FEBS Lett"},{"key":"R30-3-20210130","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1089\/aid.2006.22.998","article-title":"Membrane association and epitope recognition by HIV-1 neutralizing antigp41 2F5 and 4E10 antibodies","volume":"22","author":"Sanchez-Martinez","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R31-3-20210130","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.4049\/jimmunol.178.7.4424","article-title":"The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes","volume":"178","author":"Alam","year":"2007","journal-title":"J Immunol"},{"key":"R32-3-20210130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbrc.2007.01.033","article-title":"Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate","volume":"354","author":"Beck","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-3-20210130","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1128\/JVI.02011-06","article-title":"Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites","volume":"81","author":"Brown","year":"2007","journal-title":"J Virol"},{"key":"R34-3-20210130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/QAD.0b013e3282f51922","article-title":"4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues","volume":"22","author":"Alving","year":"2008","journal-title":"AIDS"},{"key":"R35-3-20210130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10611860802228517","article-title":"Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes","volume":"16","author":"Beck","year":"2008","journal-title":"J Drug Target"},{"key":"R36-3-20210130","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.febslet.2008.10.012","article-title":"Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies","volume":"582","author":"Huarte","year":"2008","journal-title":"FEBS Lett"},{"key":"R37-3-20210130","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1128\/JVI.00846-08","article-title":"The broadly neutralizing antihuman immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5","volume":"82","author":"Huarte","year":"2008","journal-title":"J Virol"},{"key":"R38-3-20210130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbamem.2008.11.015","article-title":"Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1","volume":"1788","author":"Matyas","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R39-3-20210130","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/QAD.0b013e32832faea5","article-title":"Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes","volume":"23","author":"Matyas","year":"2009","journal-title":"AIDS"},{"key":"R40-3-20210130","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1128\/JVI.02357-09","article-title":"Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.","volume":"84","author":"Julien","year":"2010","journal-title":"J Virol"},{"key":"R41-3-20210130","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1128\/JVI.00685-09","article-title":"A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies","volume":"83","author":"Pejchal","year":"2009","journal-title":"J Virol"},{"key":"R42-3-20210130","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1073\/pnas.0909680107","article-title":"Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions.","volume":"107","author":"Scherer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-3-20210130","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1073\/pnas.0912381107","article-title":"Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.","volume":"107","author":"Shen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-3-20210130","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/JVI.02113-09","article-title":"Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.","volume":"84","author":"Xu","year":"2010","journal-title":"J Virol"},{"key":"R45-3-20210130","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1021\/la050115m","article-title":"Dehydration damage of domain-exhibiting supported bilayers: an AFM study on the protective effects of disaccharides and other stabilizing substances","volume":"21","author":"Chiantia","year":"2005","journal-title":"Langmuir"},{"key":"R46-3-20210130","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1529\/biophysj.106.081026","article-title":"Effects of ceramide on liquid-ordered domains investigated by simultaneous AFM and FCS","volume":"90","author":"Chiantia","year":"2006","journal-title":"Biophys J"},{"key":"R47-3-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbamem.2008.08.013","article-title":"Fluorescence correlation spectroscopy in membrane structure elucidation","volume":"1788","author":"Chiantia","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R48-3-20210130","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.bpj.2008.12.3888","article-title":"Accurate determination of membrane dynamics with line-scan FCS","volume":"96","author":"Ries","year":"2009","journal-title":"Biophys J"},{"key":"R49-3-20210130","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0006-3495(04)74164-8","article-title":"Lipid lateral diffusion in ordered and disordered phases in raft mixtures","volume":"86","author":"Filippov","year":"2004","journal-title":"Biophys J"},{"key":"R50-3-20210130","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cphc.200600464","article-title":"Combined AFM and two-focus SFCS study of raft-exhibiting model membranes","volume":"7","author":"Chiantia","year":"2006","journal-title":"Chemphyschem"},{"key":"R51-3-20210130","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1073\/pnas.0511136103","article-title":"The HIV lipidome: a raft with an unusual composition","volume":"103","author":"Brugger","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R52-3-20210130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbamem.2003.12.003","article-title":"Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan","volume":"1661","author":"Moreno","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"R53-3-20210130","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1128\/JVI.00571-09","article-title":"Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions","volume":"83","author":"Dennison","year":"2009","journal-title":"J Virol"},{"key":"R54-3-20210130","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0901474106","article-title":"Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface","volume":"106","author":"Song","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201102200-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:13:21Z","timestamp":1618038801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201102200-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,20]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328342ff11","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,20]]}}}